Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records

Pharmacoepidemiology and Drug Safety

Volumn 10, Issue 6, 2001, Pages 549-554

  Van De Vijver, D A M C ^a   Roos, R A C ^b   Jansen, P A F ^c   Porsius, A J ^a   De Boer, A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antiparkinsonian drugs; Incidence; Levodopa; Logistic regression model; Parkinson's disease; Pharmacoepidemiology; Pharmacy records; Prevalence; Selegiline

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; BIPERIDEN; BROMOCRIPTINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXETIMIDE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LISURIDE; NEUROLEPTIC AGENT; ORPHENADRINE; PERGOLIDE; PLACEBO; PRAMIPEXOLE; PROCYCLIDINE; ROPINIROLE; SELEGILINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG SENSITIVITY; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PARKINSON DISEASE; PARKINSONISM; PHARMACY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; STANDARDIZATION;

AGED; ALGORITHMS; ANTIPARKINSON AGENTS; DATABASES, FACTUAL; DOCUMENTATION; DRUG UTILIZATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PARKINSON DISEASE; PHARMACIES;

EID: 0035704198     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.624     Document Type: Article

References (30)

1. Worldwide occurrence of Parkinson's disease: An updated review
2. Prevalence of Parkinson's disease and other types of parkinsonism: A door-to-door survey in three Sicilian municipalities
3. Prevalence of Parkinson's disease in the elderly: The Rotterdam study
4. Prevalence of Parkinson's disease in Junin, Buenos Aires Province, Argentina
5. Parkinson's disease and parkinsonism in a longitudinal study: Two-fold higher incidence in men
6. Information on drug use in the elderly: A comparison of pharmacy, general-practitioner and patient data
7. Validation of pharmacy records in drug exposure assessment
8. Evaluation of antiparkinsonian drugs as a marker for Parkinson's disease
9. Pharmacomorbidity linkage: A feasibility study comparing morbidity in two pharmacy based exposure cohorts
10. Measures of disease frequency
11. Introduction to stratified analysis
12. Effect of deprenyl on the progression of disability in early parkinson's disease
13. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease
14. Effect of selegiline on mortality in patients with Parkinson's disease: A meta-analysis
15. Selegiline and mortality in subjects with Parkinson's disease: A longitudinal community study
16. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP subject not requiring levodopa
17. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa
18. Tracers for paralysis agitans in epidemiological research. I. Analysis of swedish drug-use registers and tracer selection
19. Prevalence of Parkinson's disease in northwestern Italy: Comparison of tracer methodology and clinical ascertainment of cases
20. Parkinson's disease in a Scottish city
21. Parkinson's disease in Ferrara, Italy, 1967 through 1987
22. Parkinson's disease epidemiology in the Northampton District, England, 1992
23. Epidemiologic observations on Parkinson's disease: Incidence and mortality in a prospective study of middle-aged men
24. A clinical survey of parkinsonism in Iceland
25. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990
26. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community
27. Epidemiology of Parkinson's disease in Finland
28. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines